nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—ABCB1—Mitomycin—stomach cancer	0.116	0.299	CbGbCtD
Loperamide—CYP2B6—Irinotecan—stomach cancer	0.0579	0.15	CbGbCtD
Loperamide—CYP2C8—Fluorouracil—stomach cancer	0.0421	0.109	CbGbCtD
Loperamide—POMC—vagus nerve—stomach cancer	0.0385	0.274	CbGeAlD
Loperamide—CYP2B6—Doxorubicin—stomach cancer	0.0317	0.0818	CbGbCtD
Loperamide—ABCB1—Irinotecan—stomach cancer	0.0297	0.0768	CbGbCtD
Loperamide—ABCB1—Docetaxel—stomach cancer	0.0218	0.0563	CbGbCtD
Loperamide—CYP3A4—Irinotecan—stomach cancer	0.0178	0.046	CbGbCtD
Loperamide—ABCB1—Doxorubicin—stomach cancer	0.0162	0.042	CbGbCtD
Loperamide—ABCB1—Methotrexate—stomach cancer	0.0157	0.0406	CbGbCtD
Loperamide—CYP2D6—Doxorubicin—stomach cancer	0.0153	0.0395	CbGbCtD
Loperamide—CYP3A4—Docetaxel—stomach cancer	0.013	0.0337	CbGbCtD
Loperamide—POMC—blood vessel—stomach cancer	0.0118	0.084	CbGeAlD
Loperamide—CYP3A4—Doxorubicin—stomach cancer	0.00972	0.0251	CbGbCtD
Loperamide—POMC—hematopoietic system—stomach cancer	0.00628	0.0448	CbGeAlD
Loperamide—Megacolon—Methotrexate—stomach cancer	0.00536	0.0282	CcSEcCtD
Loperamide—POMC—pancreas—stomach cancer	0.00512	0.0364	CbGeAlD
Loperamide—POMC—lymphoid tissue—stomach cancer	0.00442	0.0315	CbGeAlD
Loperamide—POMC—digestive system—stomach cancer	0.00437	0.0311	CbGeAlD
Loperamide—POMC—endocrine gland—stomach cancer	0.00361	0.0257	CbGeAlD
Loperamide—POMC—liver—stomach cancer	0.00326	0.0232	CbGeAlD
Loperamide—CALM2—blood vessel—stomach cancer	0.00322	0.023	CbGeAlD
Loperamide—CALM1—blood vessel—stomach cancer	0.00321	0.0228	CbGeAlD
Loperamide—Bullous eruption—Docetaxel—stomach cancer	0.00309	0.0162	CcSEcCtD
Loperamide—CALM2—gall bladder—stomach cancer	0.00303	0.0216	CbGeAlD
Loperamide—Ileus paralytic—Capecitabine—stomach cancer	0.00273	0.0144	CcSEcCtD
Loperamide—Abdominal cramps—Irinotecan—stomach cancer	0.00262	0.0137	CcSEcCtD
Loperamide—Altered state of consciousness—Capecitabine—stomach cancer	0.00256	0.0134	CcSEcCtD
Loperamide—Ileus—Irinotecan—stomach cancer	0.0025	0.0131	CcSEcCtD
Loperamide—OPRM1—hematopoietic system—stomach cancer	0.00236	0.0168	CbGeAlD
Loperamide—Drowsiness—Mitomycin—stomach cancer	0.00228	0.012	CcSEcCtD
Loperamide—Bullous eruption—Epirubicin—stomach cancer	0.00208	0.0109	CcSEcCtD
Loperamide—Bullous eruption—Doxorubicin—stomach cancer	0.00193	0.0101	CcSEcCtD
Loperamide—CALM3—smooth muscle tissue—stomach cancer	0.00192	0.0137	CbGeAlD
Loperamide—Discomfort—Floxuridine—stomach cancer	0.00191	0.01	CcSEcCtD
Loperamide—Anaphylactic shock—Floxuridine—stomach cancer	0.00185	0.00971	CcSEcCtD
Loperamide—Nervous system disorder—Floxuridine—stomach cancer	0.00181	0.00953	CcSEcCtD
Loperamide—CALM3—pancreas—stomach cancer	0.00178	0.0127	CbGeAlD
Loperamide—Ileus—Docetaxel—stomach cancer	0.00172	0.00906	CcSEcCtD
Loperamide—CALM2—hematopoietic system—stomach cancer	0.00172	0.0122	CbGeAlD
Loperamide—CALM1—hematopoietic system—stomach cancer	0.00171	0.0122	CbGeAlD
Loperamide—Ileus—Capecitabine—stomach cancer	0.00167	0.00877	CcSEcCtD
Loperamide—CALM2—epithelium—stomach cancer	0.00157	0.0112	CbGeAlD
Loperamide—Loss of consciousness—Mitomycin—stomach cancer	0.00156	0.00821	CcSEcCtD
Loperamide—CALM1—epithelium—stomach cancer	0.00156	0.0111	CbGeAlD
Loperamide—Gastrointestinal pain—Floxuridine—stomach cancer	0.00151	0.00794	CcSEcCtD
Loperamide—CALM2—smooth muscle tissue—stomach cancer	0.00151	0.0108	CbGeAlD
Loperamide—CALM1—smooth muscle tissue—stomach cancer	0.0015	0.0107	CbGeAlD
Loperamide—Discomfort—Mitomycin—stomach cancer	0.0015	0.00786	CcSEcCtD
Loperamide—Abdominal pain—Floxuridine—stomach cancer	0.00146	0.00768	CcSEcCtD
Loperamide—CYP2C8—hematopoietic system—stomach cancer	0.00142	0.0101	CbGeAlD
Loperamide—CALM3—bone marrow—stomach cancer	0.0014	0.00998	CbGeAlD
Loperamide—CALM2—pancreas—stomach cancer	0.0014	0.00995	CbGeAlD
Loperamide—CALM1—pancreas—stomach cancer	0.00139	0.00991	CbGeAlD
Loperamide—Hypersensitivity—Floxuridine—stomach cancer	0.00136	0.00716	CcSEcCtD
Loperamide—OPRM1—endocrine gland—stomach cancer	0.00136	0.00968	CbGeAlD
Loperamide—Asthenia—Floxuridine—stomach cancer	0.00133	0.00697	CcSEcCtD
Loperamide—Anaphylactoid reaction—Irinotecan—stomach cancer	0.00132	0.00696	CcSEcCtD
Loperamide—Somnolence—Mitomycin—stomach cancer	0.00129	0.00678	CcSEcCtD
Loperamide—Dermatitis bullous—Fluorouracil—stomach cancer	0.00128	0.00675	CcSEcCtD
Loperamide—ABCB1—blood vessel—stomach cancer	0.00128	0.00912	CbGeAlD
Loperamide—CYP2B6—hematopoietic system—stomach cancer	0.00128	0.00909	CbGeAlD
Loperamide—Diarrhoea—Floxuridine—stomach cancer	0.00127	0.00665	CcSEcCtD
Loperamide—Fatigue—Mitomycin—stomach cancer	0.00125	0.00657	CcSEcCtD
Loperamide—CALM2—lymphoid tissue—stomach cancer	0.00121	0.00861	CbGeAlD
Loperamide—CALM1—lymphoid tissue—stomach cancer	0.0012	0.00857	CbGeAlD
Loperamide—CALM2—digestive system—stomach cancer	0.00119	0.0085	CbGeAlD
Loperamide—CALM1—digestive system—stomach cancer	0.00119	0.00846	CbGeAlD
Loperamide—Vomiting—Floxuridine—stomach cancer	0.00118	0.00618	CcSEcCtD
Loperamide—Rash—Floxuridine—stomach cancer	0.00117	0.00612	CcSEcCtD
Loperamide—Dermatitis—Floxuridine—stomach cancer	0.00116	0.00612	CcSEcCtD
Loperamide—Ileus—Epirubicin—stomach cancer	0.00116	0.00611	CcSEcCtD
Loperamide—Headache—Floxuridine—stomach cancer	0.00116	0.00608	CcSEcCtD
Loperamide—Depressed level of consciousness—Capecitabine—stomach cancer	0.00114	0.006	CcSEcCtD
Loperamide—CALM3—liver—stomach cancer	0.00113	0.00806	CbGeAlD
Loperamide—Abdominal distension—Irinotecan—stomach cancer	0.00112	0.00586	CcSEcCtD
Loperamide—CALM2—bone marrow—stomach cancer	0.0011	0.00784	CbGeAlD
Loperamide—Nausea—Floxuridine—stomach cancer	0.0011	0.00577	CcSEcCtD
Loperamide—CALM1—bone marrow—stomach cancer	0.0011	0.0078	CbGeAlD
Loperamide—Ileus—Doxorubicin—stomach cancer	0.00108	0.00565	CcSEcCtD
Loperamide—Asthenia—Mitomycin—stomach cancer	0.00104	0.00547	CcSEcCtD
Loperamide—Diarrhoea—Mitomycin—stomach cancer	0.000993	0.00521	CcSEcCtD
Loperamide—CALM2—endocrine gland—stomach cancer	0.000986	0.00702	CbGeAlD
Loperamide—CALM1—endocrine gland—stomach cancer	0.000982	0.00699	CbGeAlD
Loperamide—CYP3A4—hematopoietic system—stomach cancer	0.000963	0.00686	CbGeAlD
Loperamide—Dizziness—Mitomycin—stomach cancer	0.000959	0.00504	CcSEcCtD
Loperamide—CYP2D6—hematopoietic system—stomach cancer	0.000948	0.00675	CbGeAlD
Loperamide—Dermatitis bullous—Docetaxel—stomach cancer	0.000927	0.00487	CcSEcCtD
Loperamide—Vomiting—Mitomycin—stomach cancer	0.000923	0.00485	CcSEcCtD
Loperamide—Rash—Mitomycin—stomach cancer	0.000915	0.00481	CcSEcCtD
Loperamide—Dermatitis—Mitomycin—stomach cancer	0.000914	0.0048	CcSEcCtD
Loperamide—Headache—Mitomycin—stomach cancer	0.000909	0.00477	CcSEcCtD
Loperamide—CYP2B6—lymphoid tissue—stomach cancer	0.000898	0.0064	CbGeAlD
Loperamide—Dermatitis bullous—Capecitabine—stomach cancer	0.000898	0.00472	CcSEcCtD
Loperamide—CALM2—liver—stomach cancer	0.000889	0.00633	CbGeAlD
Loperamide—CYP2B6—digestive system—stomach cancer	0.000887	0.00632	CbGeAlD
Loperamide—CALM1—liver—stomach cancer	0.000885	0.0063	CbGeAlD
Loperamide—CALM3—lymph node—stomach cancer	0.000868	0.00618	CbGeAlD
Loperamide—Nausea—Mitomycin—stomach cancer	0.000862	0.00453	CcSEcCtD
Loperamide—Depressed level of consciousness—Methotrexate—stomach cancer	0.00085	0.00446	CcSEcCtD
Loperamide—CYP2C8—endocrine gland—stomach cancer	0.000817	0.00582	CbGeAlD
Loperamide—Urinary retention—Capecitabine—stomach cancer	0.000816	0.00429	CcSEcCtD
Loperamide—Abdominal pain upper—Docetaxel—stomach cancer	0.000809	0.00425	CcSEcCtD
Loperamide—Immune system disorder—Irinotecan—stomach cancer	0.000801	0.00421	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000798	0.00419	CcSEcCtD
Loperamide—Abdominal pain upper—Capecitabine—stomach cancer	0.000784	0.00412	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000773	0.00406	CcSEcCtD
Loperamide—Flatulence—Irinotecan—stomach cancer	0.000761	0.004	CcSEcCtD
Loperamide—Abdominal distension—Capecitabine—stomach cancer	0.000747	0.00392	CcSEcCtD
Loperamide—CYP2C8—liver—stomach cancer	0.000737	0.00525	CbGeAlD
Loperamide—CYP2B6—endocrine gland—stomach cancer	0.000733	0.00522	CbGeAlD
Loperamide—ABCB1—hematopoietic system—stomach cancer	0.000682	0.00486	CbGeAlD
Loperamide—CALM2—lymph node—stomach cancer	0.000682	0.00486	CbGeAlD
Loperamide—Loss of consciousness—Irinotecan—stomach cancer	0.000679	0.00356	CcSEcCtD
Loperamide—CALM1—lymph node—stomach cancer	0.000679	0.00483	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000677	0.00356	CcSEcCtD
Loperamide—CYP3A4—digestive system—stomach cancer	0.00067	0.00477	CbGeAlD
Loperamide—CYP2B6—liver—stomach cancer	0.000661	0.00471	CbGeAlD
Loperamide—Anaphylactoid reaction—Methotrexate—stomach cancer	0.00066	0.00347	CcSEcCtD
Loperamide—CYP2D6—digestive system—stomach cancer	0.000659	0.0047	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000656	0.00344	CcSEcCtD
Loperamide—Discomfort—Irinotecan—stomach cancer	0.000649	0.00341	CcSEcCtD
Loperamide—Anaphylactic shock—Irinotecan—stomach cancer	0.00063	0.00331	CcSEcCtD
Loperamide—Dermatitis bullous—Epirubicin—stomach cancer	0.000625	0.00329	CcSEcCtD
Loperamide—ABCB1—epithelium—stomach cancer	0.000623	0.00444	CbGeAlD
Loperamide—Discomfort—Fluorouracil—stomach cancer	0.000622	0.00327	CcSEcCtD
Loperamide—Nervous system disorder—Irinotecan—stomach cancer	0.000618	0.00325	CcSEcCtD
Loperamide—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000618	0.00324	CcSEcCtD
Loperamide—Urinary tract disorder—Docetaxel—stomach cancer	0.000606	0.00318	CcSEcCtD
Loperamide—Anaphylactic shock—Fluorouracil—stomach cancer	0.000604	0.00317	CcSEcCtD
Loperamide—Urethral disorder—Docetaxel—stomach cancer	0.000601	0.00316	CcSEcCtD
Loperamide—Nervous system disorder—Fluorouracil—stomach cancer	0.000592	0.00311	CcSEcCtD
Loperamide—Urinary tract disorder—Capecitabine—stomach cancer	0.000586	0.00308	CcSEcCtD
Loperamide—Urethral disorder—Capecitabine—stomach cancer	0.000582	0.00306	CcSEcCtD
Loperamide—Erythema multiforme—Docetaxel—stomach cancer	0.00058	0.00305	CcSEcCtD
Loperamide—Dermatitis bullous—Doxorubicin—stomach cancer	0.000579	0.00304	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000575	0.00302	CcSEcCtD
Loperamide—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000571	0.003	CcSEcCtD
Loperamide—Erythema multiforme—Capecitabine—stomach cancer	0.000561	0.00295	CcSEcCtD
Loperamide—Somnolence—Irinotecan—stomach cancer	0.00056	0.00294	CcSEcCtD
Loperamide—ABCB1—pancreas—stomach cancer	0.000555	0.00396	CbGeAlD
Loperamide—Dyspepsia—Irinotecan—stomach cancer	0.000555	0.00291	CcSEcCtD
Loperamide—Immune system disorder—Docetaxel—stomach cancer	0.000554	0.00291	CcSEcCtD
Loperamide—CYP3A4—endocrine gland—stomach cancer	0.000554	0.00394	CbGeAlD
Loperamide—Abdominal pain upper—Epirubicin—stomach cancer	0.000546	0.00287	CcSEcCtD
Loperamide—CYP2D6—endocrine gland—stomach cancer	0.000545	0.00388	CbGeAlD
Loperamide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000544	0.00286	CcSEcCtD
Loperamide—Fatigue—Irinotecan—stomach cancer	0.000543	0.00285	CcSEcCtD
Loperamide—Constipation—Irinotecan—stomach cancer	0.000539	0.00283	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000538	0.00283	CcSEcCtD
Loperamide—Somnolence—Fluorouracil—stomach cancer	0.000537	0.00282	CcSEcCtD
Loperamide—Immune system disorder—Capecitabine—stomach cancer	0.000536	0.00282	CcSEcCtD
Loperamide—Dyspepsia—Fluorouracil—stomach cancer	0.000531	0.00279	CcSEcCtD
Loperamide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000521	0.00274	CcSEcCtD
Loperamide—Abdominal distension—Epirubicin—stomach cancer	0.00052	0.00273	CcSEcCtD
Loperamide—Gastrointestinal pain—Irinotecan—stomach cancer	0.000515	0.00271	CcSEcCtD
Loperamide—Flatulence—Capecitabine—stomach cancer	0.000509	0.00267	CcSEcCtD
Loperamide—Abdominal pain upper—Doxorubicin—stomach cancer	0.000505	0.00265	CcSEcCtD
Loperamide—CYP3A4—liver—stomach cancer	0.000499	0.00356	CbGeAlD
Loperamide—Abdominal pain—Irinotecan—stomach cancer	0.000498	0.00262	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000498	0.00262	CcSEcCtD
Loperamide—Drowsiness—Methotrexate—stomach cancer	0.000492	0.00259	CcSEcCtD
Loperamide—CYP2D6—liver—stomach cancer	0.000491	0.0035	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000488	0.00256	CcSEcCtD
Loperamide—Abdominal distension—Doxorubicin—stomach cancer	0.000481	0.00253	CcSEcCtD
Loperamide—ABCB1—lymphoid tissue—stomach cancer	0.00048	0.00342	CbGeAlD
Loperamide—Urticaria—Fluorouracil—stomach cancer	0.000479	0.00252	CcSEcCtD
Loperamide—ABCB1—digestive system—stomach cancer	0.000474	0.00338	CbGeAlD
Loperamide—Loss of consciousness—Docetaxel—stomach cancer	0.000469	0.00246	CcSEcCtD
Loperamide—Hypersensitivity—Irinotecan—stomach cancer	0.000464	0.00244	CcSEcCtD
Loperamide—Drowsiness—Epirubicin—stomach cancer	0.000461	0.00242	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000457	0.0024	CcSEcCtD
Loperamide—Loss of consciousness—Capecitabine—stomach cancer	0.000454	0.00239	CcSEcCtD
Loperamide—Asthenia—Irinotecan—stomach cancer	0.000452	0.00237	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000451	0.00237	CcSEcCtD
Loperamide—Hypersensitivity—Fluorouracil—stomach cancer	0.000445	0.00234	CcSEcCtD
Loperamide—Dry mouth—Docetaxel—stomach cancer	0.000444	0.00233	CcSEcCtD
Loperamide—ABCB1—bone marrow—stomach cancer	0.000437	0.00311	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000437	0.0023	CcSEcCtD
Loperamide—Urinary tract disorder—Methotrexate—stomach cancer	0.000436	0.00229	CcSEcCtD
Loperamide—Anaphylactic shock—Docetaxel—stomach cancer	0.000436	0.00229	CcSEcCtD
Loperamide—Discomfort—Capecitabine—stomach cancer	0.000435	0.00228	CcSEcCtD
Loperamide—Urethral disorder—Methotrexate—stomach cancer	0.000433	0.00228	CcSEcCtD
Loperamide—Diarrhoea—Irinotecan—stomach cancer	0.000431	0.00226	CcSEcCtD
Loperamide—Dry mouth—Capecitabine—stomach cancer	0.00043	0.00226	CcSEcCtD
Loperamide—Nervous system disorder—Docetaxel—stomach cancer	0.000427	0.00224	CcSEcCtD
Loperamide—Pruritus—Fluorouracil—stomach cancer	0.000427	0.00224	CcSEcCtD
Loperamide—Drowsiness—Doxorubicin—stomach cancer	0.000426	0.00224	CcSEcCtD
Loperamide—Skin disorder—Docetaxel—stomach cancer	0.000423	0.00222	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000423	0.00222	CcSEcCtD
Loperamide—Erythema multiforme—Methotrexate—stomach cancer	0.000418	0.00219	CcSEcCtD
Loperamide—Dizziness—Irinotecan—stomach cancer	0.000417	0.00219	CcSEcCtD
Loperamide—Nervous system disorder—Capecitabine—stomach cancer	0.000414	0.00217	CcSEcCtD
Loperamide—Diarrhoea—Fluorouracil—stomach cancer	0.000413	0.00217	CcSEcCtD
Loperamide—Skin disorder—Capecitabine—stomach cancer	0.00041	0.00215	CcSEcCtD
Loperamide—Urinary tract disorder—Epirubicin—stomach cancer	0.000408	0.00215	CcSEcCtD
Loperamide—Urethral disorder—Epirubicin—stomach cancer	0.000405	0.00213	CcSEcCtD
Loperamide—Vomiting—Irinotecan—stomach cancer	0.000401	0.0021	CcSEcCtD
Loperamide—Immune system disorder—Methotrexate—stomach cancer	0.000399	0.0021	CcSEcCtD
Loperamide—Dizziness—Fluorouracil—stomach cancer	0.000399	0.0021	CcSEcCtD
Loperamide—Rash—Irinotecan—stomach cancer	0.000397	0.00209	CcSEcCtD
Loperamide—Dermatitis—Irinotecan—stomach cancer	0.000397	0.00209	CcSEcCtD
Loperamide—Headache—Irinotecan—stomach cancer	0.000395	0.00207	CcSEcCtD
Loperamide—ABCB1—endocrine gland—stomach cancer	0.000392	0.00279	CbGeAlD
Loperamide—Erythema multiforme—Epirubicin—stomach cancer	0.000391	0.00205	CcSEcCtD
Loperamide—Somnolence—Docetaxel—stomach cancer	0.000387	0.00203	CcSEcCtD
Loperamide—Vomiting—Fluorouracil—stomach cancer	0.000384	0.00202	CcSEcCtD
Loperamide—Dyspepsia—Docetaxel—stomach cancer	0.000383	0.00201	CcSEcCtD
Loperamide—Rash—Fluorouracil—stomach cancer	0.000381	0.002	CcSEcCtD
Loperamide—Dermatitis—Fluorouracil—stomach cancer	0.00038	0.002	CcSEcCtD
Loperamide—Headache—Fluorouracil—stomach cancer	0.000378	0.00199	CcSEcCtD
Loperamide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000378	0.00198	CcSEcCtD
Loperamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000376	0.00198	CcSEcCtD
Loperamide—Fatigue—Docetaxel—stomach cancer	0.000376	0.00197	CcSEcCtD
Loperamide—Urethral disorder—Doxorubicin—stomach cancer	0.000375	0.00197	CcSEcCtD
Loperamide—Nausea—Irinotecan—stomach cancer	0.000374	0.00197	CcSEcCtD
Loperamide—Immune system disorder—Epirubicin—stomach cancer	0.000374	0.00196	CcSEcCtD
Loperamide—Constipation—Docetaxel—stomach cancer	0.000373	0.00196	CcSEcCtD
Loperamide—Dyspepsia—Capecitabine—stomach cancer	0.000371	0.00195	CcSEcCtD
Loperamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000364	0.00191	CcSEcCtD
Loperamide—Fatigue—Capecitabine—stomach cancer	0.000364	0.00191	CcSEcCtD
Loperamide—Erythema multiforme—Doxorubicin—stomach cancer	0.000362	0.0019	CcSEcCtD
Loperamide—Constipation—Capecitabine—stomach cancer	0.000361	0.00189	CcSEcCtD
Loperamide—Nausea—Fluorouracil—stomach cancer	0.000358	0.00188	CcSEcCtD
Loperamide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000356	0.00187	CcSEcCtD
Loperamide—Flatulence—Epirubicin—stomach cancer	0.000355	0.00186	CcSEcCtD
Loperamide—ABCB1—liver—stomach cancer	0.000353	0.00252	CbGeAlD
Loperamide—Immune system disorder—Doxorubicin—stomach cancer	0.000346	0.00182	CcSEcCtD
Loperamide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000345	0.00181	CcSEcCtD
Loperamide—Abdominal pain—Docetaxel—stomach cancer	0.000344	0.00181	CcSEcCtD
Loperamide—Urticaria—Capecitabine—stomach cancer	0.000335	0.00176	CcSEcCtD
Loperamide—Abdominal pain—Capecitabine—stomach cancer	0.000333	0.00175	CcSEcCtD
Loperamide—Flatulence—Doxorubicin—stomach cancer	0.000328	0.00172	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000325	0.00171	CcSEcCtD
Loperamide—Discomfort—Methotrexate—stomach cancer	0.000324	0.0017	CcSEcCtD
Loperamide—Hypersensitivity—Docetaxel—stomach cancer	0.000321	0.00169	CcSEcCtD
Loperamide—Loss of consciousness—Epirubicin—stomach cancer	0.000316	0.00166	CcSEcCtD
Loperamide—Anaphylactic shock—Methotrexate—stomach cancer	0.000314	0.00165	CcSEcCtD
Loperamide—Asthenia—Docetaxel—stomach cancer	0.000313	0.00164	CcSEcCtD
Loperamide—Hypersensitivity—Capecitabine—stomach cancer	0.000311	0.00163	CcSEcCtD
Loperamide—Pruritus—Docetaxel—stomach cancer	0.000308	0.00162	CcSEcCtD
Loperamide—Nervous system disorder—Methotrexate—stomach cancer	0.000308	0.00162	CcSEcCtD
Loperamide—Skin disorder—Methotrexate—stomach cancer	0.000305	0.0016	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000304	0.0016	CcSEcCtD
Loperamide—Discomfort—Epirubicin—stomach cancer	0.000303	0.00159	CcSEcCtD
Loperamide—Asthenia—Capecitabine—stomach cancer	0.000303	0.00159	CcSEcCtD
Loperamide—Dry mouth—Epirubicin—stomach cancer	0.0003	0.00157	CcSEcCtD
Loperamide—Pruritus—Capecitabine—stomach cancer	0.000298	0.00157	CcSEcCtD
Loperamide—Diarrhoea—Docetaxel—stomach cancer	0.000298	0.00157	CcSEcCtD
Loperamide—Anaphylactic shock—Epirubicin—stomach cancer	0.000294	0.00154	CcSEcCtD
Loperamide—Loss of consciousness—Doxorubicin—stomach cancer	0.000293	0.00154	CcSEcCtD
Loperamide—Diarrhoea—Capecitabine—stomach cancer	0.000289	0.00152	CcSEcCtD
Loperamide—Nervous system disorder—Epirubicin—stomach cancer	0.000288	0.00151	CcSEcCtD
Loperamide—Dizziness—Docetaxel—stomach cancer	0.000288	0.00151	CcSEcCtD
Loperamide—Skin disorder—Epirubicin—stomach cancer	0.000285	0.0015	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000282	0.00148	CcSEcCtD
Loperamide—Discomfort—Doxorubicin—stomach cancer	0.00028	0.00147	CcSEcCtD
Loperamide—Somnolence—Methotrexate—stomach cancer	0.000279	0.00147	CcSEcCtD
Loperamide—Dizziness—Capecitabine—stomach cancer	0.000279	0.00146	CcSEcCtD
Loperamide—Dry mouth—Doxorubicin—stomach cancer	0.000277	0.00146	CcSEcCtD
Loperamide—Vomiting—Docetaxel—stomach cancer	0.000277	0.00145	CcSEcCtD
Loperamide—Dyspepsia—Methotrexate—stomach cancer	0.000276	0.00145	CcSEcCtD
Loperamide—Rash—Docetaxel—stomach cancer	0.000275	0.00144	CcSEcCtD
Loperamide—Dermatitis—Docetaxel—stomach cancer	0.000274	0.00144	CcSEcCtD
Loperamide—Headache—Docetaxel—stomach cancer	0.000273	0.00143	CcSEcCtD
Loperamide—Anaphylactic shock—Doxorubicin—stomach cancer	0.000272	0.00143	CcSEcCtD
Loperamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000271	0.00142	CcSEcCtD
Loperamide—ABCB1—lymph node—stomach cancer	0.000271	0.00193	CbGeAlD
Loperamide—Fatigue—Methotrexate—stomach cancer	0.000271	0.00142	CcSEcCtD
Loperamide—Vomiting—Capecitabine—stomach cancer	0.000268	0.00141	CcSEcCtD
Loperamide—Nervous system disorder—Doxorubicin—stomach cancer	0.000267	0.0014	CcSEcCtD
Loperamide—Rash—Capecitabine—stomach cancer	0.000266	0.0014	CcSEcCtD
Loperamide—Dermatitis—Capecitabine—stomach cancer	0.000266	0.0014	CcSEcCtD
Loperamide—Headache—Capecitabine—stomach cancer	0.000264	0.00139	CcSEcCtD
Loperamide—Skin disorder—Doxorubicin—stomach cancer	0.000264	0.00139	CcSEcCtD
Loperamide—Somnolence—Epirubicin—stomach cancer	0.000261	0.00137	CcSEcCtD
Loperamide—Nausea—Docetaxel—stomach cancer	0.000259	0.00136	CcSEcCtD
Loperamide—Dyspepsia—Epirubicin—stomach cancer	0.000259	0.00136	CcSEcCtD
Loperamide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000257	0.00135	CcSEcCtD
Loperamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000254	0.00133	CcSEcCtD
Loperamide—Fatigue—Epirubicin—stomach cancer	0.000253	0.00133	CcSEcCtD
Loperamide—Constipation—Epirubicin—stomach cancer	0.000251	0.00132	CcSEcCtD
Loperamide—Nausea—Capecitabine—stomach cancer	0.000251	0.00132	CcSEcCtD
Loperamide—Urticaria—Methotrexate—stomach cancer	0.000249	0.00131	CcSEcCtD
Loperamide—Abdominal pain—Methotrexate—stomach cancer	0.000248	0.0013	CcSEcCtD
Loperamide—Somnolence—Doxorubicin—stomach cancer	0.000242	0.00127	CcSEcCtD
Loperamide—Gastrointestinal pain—Epirubicin—stomach cancer	0.00024	0.00126	CcSEcCtD
Loperamide—Dyspepsia—Doxorubicin—stomach cancer	0.000239	0.00126	CcSEcCtD
Loperamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000235	0.00123	CcSEcCtD
Loperamide—Fatigue—Doxorubicin—stomach cancer	0.000234	0.00123	CcSEcCtD
Loperamide—Urticaria—Epirubicin—stomach cancer	0.000233	0.00123	CcSEcCtD
Loperamide—Constipation—Doxorubicin—stomach cancer	0.000232	0.00122	CcSEcCtD
Loperamide—Abdominal pain—Epirubicin—stomach cancer	0.000232	0.00122	CcSEcCtD
Loperamide—Hypersensitivity—Methotrexate—stomach cancer	0.000231	0.00122	CcSEcCtD
Loperamide—Asthenia—Methotrexate—stomach cancer	0.000225	0.00118	CcSEcCtD
Loperamide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000222	0.00117	CcSEcCtD
Loperamide—Pruritus—Methotrexate—stomach cancer	0.000222	0.00117	CcSEcCtD
Loperamide—Hypersensitivity—Epirubicin—stomach cancer	0.000216	0.00114	CcSEcCtD
Loperamide—Urticaria—Doxorubicin—stomach cancer	0.000216	0.00113	CcSEcCtD
Loperamide—Abdominal pain—Doxorubicin—stomach cancer	0.000215	0.00113	CcSEcCtD
Loperamide—Diarrhoea—Methotrexate—stomach cancer	0.000215	0.00113	CcSEcCtD
Loperamide—Asthenia—Epirubicin—stomach cancer	0.000211	0.00111	CcSEcCtD
Loperamide—Pruritus—Epirubicin—stomach cancer	0.000208	0.00109	CcSEcCtD
Loperamide—Dizziness—Methotrexate—stomach cancer	0.000208	0.00109	CcSEcCtD
Loperamide—Diarrhoea—Epirubicin—stomach cancer	0.000201	0.00106	CcSEcCtD
Loperamide—Hypersensitivity—Doxorubicin—stomach cancer	0.0002	0.00105	CcSEcCtD
Loperamide—Vomiting—Methotrexate—stomach cancer	0.0002	0.00105	CcSEcCtD
Loperamide—Rash—Methotrexate—stomach cancer	0.000198	0.00104	CcSEcCtD
Loperamide—Dermatitis—Methotrexate—stomach cancer	0.000198	0.00104	CcSEcCtD
Loperamide—Headache—Methotrexate—stomach cancer	0.000197	0.00103	CcSEcCtD
Loperamide—Asthenia—Doxorubicin—stomach cancer	0.000195	0.00102	CcSEcCtD
Loperamide—Dizziness—Epirubicin—stomach cancer	0.000194	0.00102	CcSEcCtD
Loperamide—Pruritus—Doxorubicin—stomach cancer	0.000192	0.00101	CcSEcCtD
Loperamide—Vomiting—Epirubicin—stomach cancer	0.000187	0.000981	CcSEcCtD
Loperamide—Nausea—Methotrexate—stomach cancer	0.000186	0.00098	CcSEcCtD
Loperamide—Diarrhoea—Doxorubicin—stomach cancer	0.000186	0.000977	CcSEcCtD
Loperamide—Rash—Epirubicin—stomach cancer	0.000185	0.000973	CcSEcCtD
Loperamide—Dermatitis—Epirubicin—stomach cancer	0.000185	0.000972	CcSEcCtD
Loperamide—Headache—Epirubicin—stomach cancer	0.000184	0.000967	CcSEcCtD
Loperamide—Dizziness—Doxorubicin—stomach cancer	0.00018	0.000944	CcSEcCtD
Loperamide—Nausea—Epirubicin—stomach cancer	0.000175	0.000917	CcSEcCtD
Loperamide—Vomiting—Doxorubicin—stomach cancer	0.000173	0.000908	CcSEcCtD
Loperamide—Rash—Doxorubicin—stomach cancer	0.000171	0.0009	CcSEcCtD
Loperamide—Dermatitis—Doxorubicin—stomach cancer	0.000171	0.0009	CcSEcCtD
Loperamide—Headache—Doxorubicin—stomach cancer	0.00017	0.000895	CcSEcCtD
Loperamide—Nausea—Doxorubicin—stomach cancer	0.000161	0.000848	CcSEcCtD
Loperamide—CALM1—Adaptive Immune System—HRAS—stomach cancer	7.28e-06	2.58e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—stomach cancer	7.26e-06	2.57e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—stomach cancer	7.26e-06	2.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CAV1—stomach cancer	7.25e-06	2.57e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CAV1—stomach cancer	7.25e-06	2.57e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOA1—stomach cancer	7.24e-06	2.56e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOA1—stomach cancer	7.24e-06	2.56e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—JUN—stomach cancer	7.23e-06	2.56e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—stomach cancer	7.22e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—stomach cancer	7.22e-06	2.55e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MYC—stomach cancer	7.18e-06	2.54e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—stomach cancer	7.16e-06	2.54e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—stomach cancer	7.16e-06	2.54e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK8—stomach cancer	7.15e-06	2.53e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRKCB—stomach cancer	7.14e-06	2.53e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6ST—stomach cancer	7.11e-06	2.52e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—stomach cancer	7.09e-06	2.51e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK1—stomach cancer	7.03e-06	2.49e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—stomach cancer	7.03e-06	2.49e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN1B—stomach cancer	7.01e-06	2.48e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDKN1A—stomach cancer	7.01e-06	2.48e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—JUN—stomach cancer	6.99e-06	2.48e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—JUN—stomach cancer	6.99e-06	2.48e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—stomach cancer	6.97e-06	2.47e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	6.95e-06	2.46e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—stomach cancer	6.94e-06	2.46e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCB—stomach cancer	6.9e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCB—stomach cancer	6.9e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6ST—stomach cancer	6.87e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6ST—stomach cancer	6.87e-06	2.43e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—stomach cancer	6.86e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—stomach cancer	6.86e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—stomach cancer	6.86e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK8—stomach cancer	6.84e-06	2.42e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APC—stomach cancer	6.83e-06	2.42e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAV1—stomach cancer	6.79e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN1B—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN1B—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDKN1A—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDKN1A—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—stomach cancer	6.78e-06	2.4e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—stomach cancer	6.73e-06	2.38e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CD44—stomach cancer	6.7e-06	2.37e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KRAS—stomach cancer	6.64e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK8—stomach cancer	6.62e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK8—stomach cancer	6.62e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APC—stomach cancer	6.61e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APC—stomach cancer	6.61e-06	2.34e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—stomach cancer	6.6e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—stomach cancer	6.56e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—stomach cancer	6.56e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MAPK3—stomach cancer	6.54e-06	2.31e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STAT3—stomach cancer	6.53e-06	2.31e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN1A—stomach cancer	6.47e-06	2.29e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—stomach cancer	6.43e-06	2.28e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAV1—stomach cancer	6.4e-06	2.27e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—stomach cancer	6.39e-06	2.26e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—stomach cancer	6.37e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6R—stomach cancer	6.34e-06	2.24e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MAPK3—stomach cancer	6.33e-06	2.24e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MAPK3—stomach cancer	6.33e-06	2.24e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN1A—stomach cancer	6.26e-06	2.22e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN1A—stomach cancer	6.26e-06	2.22e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—STAT3—stomach cancer	6.25e-06	2.21e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK3—stomach cancer	6.24e-06	2.21e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MAPK1—stomach cancer	6.22e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—stomach cancer	6.22e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—stomach cancer	6.2e-06	2.19e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—stomach cancer	6.17e-06	2.18e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—stomach cancer	6.16e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6R—stomach cancer	6.13e-06	2.17e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6R—stomach cancer	6.13e-06	2.17e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	6.1e-06	2.16e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MYC—stomach cancer	6.07e-06	2.15e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—STAT3—stomach cancer	6.05e-06	2.14e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—stomach cancer	6.05e-06	2.14e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MAPK1—stomach cancer	6.02e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MAPK1—stomach cancer	6.02e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—stomach cancer	6.02e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—stomach cancer	6.02e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—stomach cancer	6e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—stomach cancer	6e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK3—stomach cancer	5.98e-06	2.12e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—stomach cancer	5.97e-06	2.11e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK1—stomach cancer	5.94e-06	2.1e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—stomach cancer	5.94e-06	2.1e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—stomach cancer	5.94e-06	2.1e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—stomach cancer	5.9e-06	2.09e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—stomach cancer	5.9e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—KRAS—stomach cancer	5.88e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK3—stomach cancer	5.78e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK3—stomach cancer	5.78e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—stomach cancer	5.77e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—stomach cancer	5.74e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—stomach cancer	5.74e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RHOA—stomach cancer	5.73e-06	2.03e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.7e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK1—stomach cancer	5.69e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—KRAS—stomach cancer	5.69e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—KRAS—stomach cancer	5.69e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—stomach cancer	5.68e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—stomach cancer	5.67e-06	2.01e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—stomach cancer	5.64e-06	2e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—stomach cancer	5.63e-06	1.99e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KRAS—stomach cancer	5.61e-06	1.99e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—stomach cancer	5.59e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—stomach cancer	5.59e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—stomach cancer	5.59e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RHOA—stomach cancer	5.54e-06	1.96e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RHOA—stomach cancer	5.54e-06	1.96e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MAPK3—stomach cancer	5.52e-06	1.95e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—stomach cancer	5.51e-06	1.95e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK1—stomach cancer	5.5e-06	1.95e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK1—stomach cancer	5.5e-06	1.95e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—stomach cancer	5.5e-06	1.95e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—stomach cancer	5.5e-06	1.95e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—stomach cancer	5.48e-06	1.94e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—stomach cancer	5.48e-06	1.94e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PIK3CA—stomach cancer	5.4e-06	1.91e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—stomach cancer	5.4e-06	1.91e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—stomach cancer	5.39e-06	1.91e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—stomach cancer	5.37e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—KRAS—stomach cancer	5.37e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MYC—stomach cancer	5.37e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MAPK3—stomach cancer	5.34e-06	1.89e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MAPK3—stomach cancer	5.34e-06	1.89e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB2—stomach cancer	5.3e-06	1.88e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MAPK1—stomach cancer	5.25e-06	1.86e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—stomach cancer	5.25e-06	1.86e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PIK3CA—stomach cancer	5.22e-06	1.85e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PIK3CA—stomach cancer	5.22e-06	1.85e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TYMS—stomach cancer	5.2e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—KRAS—stomach cancer	5.19e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—KRAS—stomach cancer	5.19e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MYC—stomach cancer	5.19e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MYC—stomach cancer	5.19e-06	1.84e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	5.15e-06	1.82e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—stomach cancer	5.14e-06	1.82e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—stomach cancer	5.14e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB2—stomach cancer	5.13e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB2—stomach cancer	5.13e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MAPK1—stomach cancer	5.08e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MAPK1—stomach cancer	5.08e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—stomach cancer	5.08e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—stomach cancer	5.08e-06	1.8e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—stomach cancer	5.06e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—stomach cancer	5.03e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—stomach cancer	5e-06	1.77e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—stomach cancer	4.99e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—KRAS—stomach cancer	4.96e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—PIK3CA—stomach cancer	4.93e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1B—stomach cancer	4.91e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—stomach cancer	4.86e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—stomach cancer	4.86e-06	1.72e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—stomach cancer	4.84e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—stomach cancer	4.83e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—stomach cancer	4.83e-06	1.71e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ERCC2—stomach cancer	4.83e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—KRAS—stomach cancer	4.8e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—KRAS—stomach cancer	4.8e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—stomach cancer	4.78e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—PIK3CA—stomach cancer	4.77e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—PIK3CA—stomach cancer	4.77e-06	1.69e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—stomach cancer	4.77e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1B—stomach cancer	4.75e-06	1.68e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1B—stomach cancer	4.75e-06	1.68e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—stomach cancer	4.7e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCND1—stomach cancer	4.68e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—JUN—stomach cancer	4.67e-06	1.65e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—stomach cancer	4.63e-06	1.64e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—stomach cancer	4.63e-06	1.64e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—stomach cancer	4.56e-06	1.62e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—stomach cancer	4.56e-06	1.62e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PIK3CA—stomach cancer	4.56e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—stomach cancer	4.55e-06	1.61e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—stomach cancer	4.54e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1A—stomach cancer	4.53e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCND1—stomach cancer	4.53e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCND1—stomach cancer	4.53e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—JUN—stomach cancer	4.52e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—JUN—stomach cancer	4.52e-06	1.6e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—stomach cancer	4.43e-06	1.57e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—stomach cancer	4.42e-06	1.57e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—stomach cancer	4.42e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—stomach cancer	4.42e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PIK3CA—stomach cancer	4.41e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PIK3CA—stomach cancer	4.41e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—stomach cancer	4.4e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—stomach cancer	4.4e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1A—stomach cancer	4.38e-06	1.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1A—stomach cancer	4.38e-06	1.55e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—stomach cancer	4.37e-06	1.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—stomach cancer	4.28e-06	1.51e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—stomach cancer	4.28e-06	1.51e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—stomach cancer	4.23e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—stomach cancer	4.23e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—stomach cancer	4.21e-06	1.49e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAV1—stomach cancer	4.19e-06	1.48e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—stomach cancer	4.18e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—stomach cancer	4.08e-06	1.45e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—stomach cancer	4.08e-06	1.44e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—stomach cancer	4.08e-06	1.44e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—stomach cancer	4.04e-06	1.43e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—stomach cancer	4.03e-06	1.43e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—stomach cancer	3.95e-06	1.4e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—stomach cancer	3.95e-06	1.4e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CA—stomach cancer	3.92e-06	1.39e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—stomach cancer	3.91e-06	1.38e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—stomach cancer	3.91e-06	1.38e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—stomach cancer	3.9e-06	1.38e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—stomach cancer	3.9e-06	1.38e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK3—stomach cancer	3.86e-06	1.37e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CA—stomach cancer	3.81e-06	1.35e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MYC—stomach cancer	3.76e-06	1.33e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK3—stomach cancer	3.74e-06	1.32e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK3—stomach cancer	3.74e-06	1.32e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CA—stomach cancer	3.69e-06	1.31e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CA—stomach cancer	3.69e-06	1.31e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—stomach cancer	3.68e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK1—stomach cancer	3.68e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—stomach cancer	3.68e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MYC—stomach cancer	3.63e-06	1.29e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MYC—stomach cancer	3.63e-06	1.29e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK1—stomach cancer	3.56e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK1—stomach cancer	3.56e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—stomach cancer	3.56e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—stomach cancer	3.56e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KRAS—stomach cancer	3.47e-06	1.23e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KRAS—stomach cancer	3.36e-06	1.19e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KRAS—stomach cancer	3.36e-06	1.19e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CA—stomach cancer	3.32e-06	1.17e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—stomach cancer	3.31e-06	1.17e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CA—stomach cancer	3.19e-06	1.13e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—stomach cancer	3.17e-06	1.12e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—stomach cancer	3.09e-06	1.09e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CA—stomach cancer	3.09e-06	1.09e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CA—stomach cancer	3.09e-06	1.09e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—stomach cancer	2.99e-06	1.06e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—stomach cancer	2.99e-06	1.06e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—stomach cancer	2.95e-06	1.04e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—stomach cancer	2.9e-06	1.02e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CA—stomach cancer	2.89e-06	1.02e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—stomach cancer	2.85e-06	1.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—stomach cancer	2.85e-06	1.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—stomach cancer	2.82e-06	1e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—stomach cancer	2.73e-06	9.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—stomach cancer	2.73e-06	9.67e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.72e-06	9.64e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.78e-06	6.3e-06	CbGpPWpGaD
